Beta cell protective effects of sodium tungstate in streptozotocin-induced diabetic rats: Glycemic control, blockage of oxidative stress and beta cell histochemistry

Iranian Biomedical Journal

Volumn 12, Issue 3, 2008, Pages 143-152

  Heidari, Zahra ^a   Harati, Mehdi ^a   Mahmoudzadeh Sagheb, Hamid Reza ^a   Moudi, Bita ^b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Beta cells; Diabetes mellitus; Sodium tungstate

Indexed keywords

ANTIDIABETIC AGENT; GLUCOKINASE; TUNGSTATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GLYCOGEN LIVER LEVEL; HISTOCHEMISTRY; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID PEROXIDATION; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; RAT; STREPTOZOCIN DIABETES;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY WEIGHT; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; FEEDING BEHAVIOR; GLUCOKINASE; GLUCOSE; GLYCOGEN; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUNGSTEN COMPOUNDS;

ANIMALIA; RATTUS;

EID: 61349101433     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mohamad, A.K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, H., and Nawroth, P.P. (1999) The role of oxidative stress and NF (B) activation in late diabetic complication. Biofactors 10: 171-179.
2. VanDam, P.S., and Bravenboer, B. (1997) Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci. Res. Commun. 21: 41-48.
3. Maxwell, S.R., Thopson, H., Sandler, D., Leguen, C., Baxter, M.A., Thrope, G.H., Jones, A.F., and Barnett, A.H. (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 27: 484-490.
4. Santini, S.A., Marra, G., Giardina, B., Cotroneo, P., Mordenete, A., Martorana, G.E., Manto, A., and Ghirlanda, G. (1997) Defective plasma antioxidant defaces and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46: 1853-1858.
5. Wild, S., Roglic, K., Green, A., Sicree, R., and King, H. (2004) Global prevalence of diabetes. Estimation for the year 2000 and projections for 2030. Diabetes Care. 27: 1047-1053.
6. Gao, L.H., Liu, W.P., and Wang, B.L. (2006) Effects of bis (alpha-furancarboxylato) oxovanadium (IV) on non-diabetic and streptozotocin-diabetic rats. Clin. Chim. Acta. 368: 173-178.
7. Harati, M., and Ani, M. (2004) Vanadyl sulfate ameliorates insulin resistance and restores plasma dehydroepiandrostrone-sulfate levels in fructose-fed, insulin resistant rats. Clin. Biochem. 37: 694- 697.
8. Trumbo, P.R., and Ellwood, K.C. (2006) Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration. Nut. Rev. 64: 357-363.
9. Ozcelikay, A.T., Becker, D.J., Ongemba, L.N., Pottier, A.M., Henquin, J.C., and Brichard, S.M. (1996) Improvement of glucose and lipid metabolism in diabetic rats treated with molybdate. Am. J. Physiol. 270: E344-E352.
10. Vasudevan, H., and McNeill, J.H. (2007) Chronic cobalt treatment decreases hyperglycemia in streptozotocin-diabetic rats. Biometals. 20 (2):129-134.
11. Partida-Hernandez, G., Arrola, F., Fenton, B., Cabeza, M., and Roman-Ramos, R. (2006) Effect of zinc replacement on lipid and lipoproteins in type 2-diabetic patients. Biomed. Pharmacol. 60: 161-168.
12. Barbera, A., Rodriguez-Gil, J.E., and Guinovart, J.J. (1994) Insulin-like actions of tungstate in diabetic rats, Normalization of hepatic glucose metabolism. J. Biol. Chem. 269: 20047- 20053.
13. Barbera, A., Fernardez-Averez, J., Truce, A., Gomis, R., and Guinovart, J.J. (1997) Effects of tungstate in neontally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycemia. Diabetologia 40: 143-149.
14. Barbera, A., Gomis, R.R., and Parts, N. (2001) Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rat: a long-term study. Diabetologia 44: 507-513.
15. Li, J., Elberg, G., Gefel, D., and Shechter, Y. (1995) Permolybdate and pertungstate-potent stimulators of insulin effects in rat adipocytes: mechanism of action. Biochemistry 34: 6218-6225.
16. Munoz, M.R., Barbera, A., Dominguez, J., Fernandez-Alvarez, J., and Gomis R, R. (2001) Effects of tungstate, a new potential oral antidiabetic agent, in zucker diabetic fatty rats. Diabetes 50: 131-138.
17. Fernandez-Alvarez, J., Barbera, A., Nadal, B., Barcelo-Batllori, S., Piquer, S., and claret, M. (2004) Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia. 47: 470- 477.
18. Kawasaki, E., Abiru, N., and Eguchi, K. (2004) Prevention of type 1 diabetes: from the view point of β cell damage. Diabetes. Res. Clin. Prac. 66: S27-S32.
19. Hassid, W.Z., and Abrahams, S. (1966) Chemical procedure for analysis of polysaccharides. In: Colowick SP, Kaplan NO, editors. Methods in enzymology. Vol 3. CA: Academy press Co. New York. USA. pp. 34-37.
20. Davidson, A.L., and Arion, W.J. (1987) Factors underlying significant understanding of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch. Biochem. Biophy. 253: 156-167.
21. Jain, S.K., and Levine, S.N. (1995) Elevated lipid peroxidation and vitamine E-quinon levels in heart ventricles of streptozotocin-traeted diabetic rats. Free. Radic. Biol. Med. 18: 337- 341.
22. Benzie, I.F.F., and Strain, J.J. (1999) The ferric reducing/antioxidant power: Direct measured of the total antioxidant activity of biological fluids and modified version for simulations measurement of total antioxidant power and ascorbic acid concentration. Med. Enzymol. 299: 15-27.
23. Lowery, O.H., Rosebrough, N.N., Far, A.L., and Randall, R.J. (1952) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
24. Bancroft, J.D. Gamble, M. (2002) Theory and practice of histological technique. 5th edition, Churchil Livingston, London. pp. 556-557 and 364.
25. Takasu, N., Asawa, T., Komiya, I., Nagasawa, Y., and Yamada, T. (1991) Alloxan-induced DNA trend breaks in pancreatic islets. J.Biol.Chem. 266: 2112-2114.
26. Elliot, J.F. (1998) New approaches to preventing and treating Type 1 diabetes: discovering a method to preserve β cell mass after diagnosis should remain a key research focus. Can. J. Diabetes. Care. 138: 168-174.
27. Thulesen, J., Orskov, C., Holst, J.J., Seier, S., and Poulsen, S. (1997) Short term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinol. 138: 62-68.
28. Eiziric, D.L., Strandell, S., and Sandler, S. (1988) Culture of mouse pancreatic islets in different glucose concentrations modifies β cell sensitivity to streptozotocin. Diabetologia. 31: 51-57.
29. Cam, M.C., Rodrigues, B., and McNeill, J.H. (1999) Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes. Eur. J. Endocrinol. 141: 546-554.
30. Vijayakumar, M., Govindrajan, R., Rao, G.M.M., Rao, C.V., Shirwaikar, A., Mehrota, S., and Pushpangadan, P. (2006) Action of Hygrophila auriculata against streptozotocin-induced oxidative stress. J. Ethnopharmacol. 104: 356-361.
31. Baynes, J.W., and Thorpe, S.R. (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 48: 1-9.
32. Motilla, P.L., Vargas, J.F., Tunez, I.F., Munoz De Agueda, M.C., Valdelvira, M.E., and Cabrera, E.S. (1998) Oxidative stress in diabetic rats induced by streptozotocin: preventive effects of melatonin. J. Pineal. Res. 25: 94-100.
33. Seghrouchi, I., Dari, J., Bannier, E., Riviere, J., Calmard, P., Garcia, I., Orgiazzi, J., and Revol, A. (2002) Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficacy. Clin. Chim. Acta. 321: 89-96.
34. Cakatay, U., and kayali, R. (2006) The evaluation of altered redox status in plasma and mitochondria of acute and chronic diabetic rats. Clin. Biochem. 39: 907-912.
35. Sato, K., M. Ichimasa, K. Miyahara, M. Shiomi, Y. Nishimura, and Y. Ichimasa. (1999) Radioprotective effects of sodium tungstate on hematopoietic injury by exposure to 60Co gamma rays in Wistar rats. J. Radiat. Res. 40 (2): 101-113.
36. Ramachandran, B., Ravi, K., Narayanan, V., Kandaswamy, M., and Subramanian, S. (2004) Protective effect of macrocyclic binuclear oxovanadium complex on oxidative stress in pancreas of streptozotocin induced diabetic rats. Chem. Boil. Interact. 149: 9-21.